Key Takeaways
Massive U.S. Commitment: British drugmaker GSK announced a five-year, $30 billion investment in U.S. research, development, and manufacturing, including a new biologics “flex” factory in Pennsylvania.
Trump’s Policy Influence: The move reflects President Trump’s push for Big Pharma to bring operations...
